BBOT
BridgeBio Oncology Therapeutics, Inc. Common Stock
BBOT
BBOT
31 hedge funds and large institutions have $167M invested in BridgeBio Oncology Therapeutics, Inc. Common Stock in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
31
Holders Change
+2
Holders Change %
+6.9%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
5
Reduced
3
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
1 |
1
Wellington Management Group
Boston,
Massachusetts
|
$1.89M |
2 |
CAC
2
Cowen and Company
New York
|
$516K |
3 |
WP
3
Woodline Partners
San Francisco,
California
|
$1.06M |